Federated Hermes’s Compass Therapeutics CMPX Stock Holding History

Federated Hermes’s Portfolio CMPX Stock Details CMPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,592	Closed	-$3.59K	–	2076
2024 Q2	$3.59K	Buy	3,592 +2,659	+285%	+$3.88K	﹤0.01%	1869
2024 Q1	$1.85K	Sell	933 -2,608	-74%	-$4.51K	﹤0.01%	1927
2023 Q4	$5.52K	Buy	+3,541	New	+$6.13K	﹤0.01%	1841

Other funds holding CMPX

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Federated Hermes's CMPX Position: Q3 2024 in Review

Federated Hermes sold out of Compass Therapeutics (CMPX) in Q3 2024, closing a stake of 3,592 shares — an estimated $3.59K sold.

Federated Hermes first reported a position in CMPX in Q4 2023 and held it in 3 quarters. The position peaked at $5.52K in Q4 2023. 79 funds tracked by Wall St. Rank hold CMPX as of Q3 2024.

Federated Hermes reported no remaining Compass Therapeutics position as of Q3 2024 after selling out during the quarter.
Federated Hermes sold 3,592 Compass Therapeutics shares in Q3 2024, an estimated $3.59K.
Federated Hermes first reported a position in Compass Therapeutics in Q4 2023 and held it in 3 quarters.
Federated Hermes's Compass Therapeutics position peaked at $5.52K in Q4 2023.
79 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2024.

Based on Federated Hermes's 13F filing for Q3 2024, filed 13 Nov 2024.